Mylan Says Teva Offer Too Low and Stock 'Unacceptable'

Teva, the world's biggest maker of generic drugs, last week offered $82 per share in cash and stock for smaller rival Mylan.

Reuters
Send in e-mailSend in e-mail
Teva's headquarters in Jerusalem.
Teva's headquarters in Jerusalem.Credit: Bloomberg
Reuters

Comments